KKR & Co. Inc. quarterly report, Q3 FY2025

Business Context and Reporting Period

This summary covers KKR & Co. Inc.'s (KKR) Form 10-Q for the quarterly period ended September 30, 2025. KKR is a leading global investment firm operating through three primary segments: Asset Management (private equity, credit, real assets, and capital markets), Insurance (Global Atlantic), and Strategic Holdings (core private equity portfolio companies). The company reported strong liquidity with total assets of $398.5 billion and stockholders' equity of $29.7 billion as of the period end.

Key Financial Metrics

Metric Three Months Ended Sept 30, 2025 Nine Months Ended Sept 30, 2025
Total Revenues $5.53 billion $13.73 billion
Net Income (Consolidated) $1.84 billion $3.88 billion
Net Income Attributable to KKR Common Stockholders $859.9 million $1.15 billion
Diluted EPS (Common Stockholders) $0.90 $1.19
Total Segment Earnings (Non-GAAP) $1.70 billion $4.52 billion
Adjusted Net Income (Non-GAAP) $1.27 billion $3.37 billion
Cash and Cash Equivalents (Total) $22.89 billion N/A
Total Debt Obligations $53.12 billion N/A

Material Changes vs. Prior Comparable Period

  • Revenue Growth: Total revenues increased by 15.3% year-over-year for the quarter, driven primarily by a 50.3% increase in Insurance revenues (due to higher net premiums and investment income) and a 3.2% increase in Total Segment Earnings.
  • Asset Management Performance: Asset Management Segment Earnings rose to $1.27 billion for the quarter, up from $1.23 billion in the prior year, supported by higher management fees and realized performance income, despite a decrease in transaction fees.
  • Insurance Segment: Insurance Operating Earnings increased to $304.7 million from $238.5 million, driven by higher net investment income and favorable assumption review impacts, partially offset by higher net costs of insurance.
  • Strategic Holdings: Segment Earnings grew significantly to $127.5 million from $94.5 million, primarily due to increased dividend income from portfolio companies.
  • Capital Allocation: KKR issued $2.59 billion of Series D Mandatory Convertible Preferred Stock in March 2025. Additionally, the company acquired a majority stake in HealthCare Royalty Management, LLC in July 2025.

Guidance, Outlook, and Risks

  • Dividends: A quarterly dividend of $0.185 per common share was declared, payable December 2, 2025. A dividend of $0.78125 per Series D Preferred share was also declared.
  • Share Repurchases: As of October 31, 2025, approximately $440 million remained under the share repurchase program. No common shares were repurchased in Q3 2025, though 8,333 equity awards were retired.
  • Clawback Obligations: Management expects an Asian Fund II clawback obligation of approximately $346 million to be realized in Q4 2025, which is expected to reduce net realized performance income by $210 million on a net basis.
  • Legal Proceedings: KKR is defending against a civil antitrust complaint filed by the DOJ regarding HSR Act filings. A settlement agreement with the Commonwealth of Kentucky regarding fiduciary duty claims terminated in May 2025 after the court declined to approve it; KKR intends to continue defending the claims.
  • Market Risks: The company faces sensitivity to interest rate changes, equity market volatility, and credit spreads, particularly within its Global Atlantic insurance portfolio and Level III investment valuations.

Investor Verification Checklist

  • Clawback Impact: Verify the timing and magnitude of the expected $210 million net reduction in realized performance income due to the Asian Fund II clawback in Q4 2025.
  • Insurance Assumptions: Review the specific actuarial assumption changes (mortality, surrender rates, yields) that drove the favorable $106.2 million impact on net policy benefits and claims in Q3.
  • Debt Maturities: Confirm the schedule for upcoming debt maturities, including the $750 million KKR USD Senior Notes due within 5 years and the $1.5 billion KKR Yen Senior Notes.
  • Legal Exposure: Monitor the status of the DOJ antitrust litigation and the Kentucky fiduciary duty lawsuits for potential financial penalties or settlements.
  • Series D Conversion: Track the conversion terms of the $2.59 billion Series D Mandatory Convertible Preferred Stock, which is expected to convert to common stock on March 1, 2028.